why does semaglutide cause heart palpitations Palpitations: Causes and When to Worry Semaglutide and the Heart: Focus

CI=confidence interval

STEP 5, the longest trial at 104 weeks, showed that weight loss was sustained over two years of continuous treatment

Food and Drug Administration (FDA) approved Wegovy for reducing the risk of heart attack, stroke, and cardiovascular death in adult patients with cardiovascular diseases and obesity or overweight as an adjunct to dietary modifications and increased physical activity

This work was eventually published in the JBC journal in August 1991

By boosting insulin release, decreasing hunger, and delaying gastric emptying, this medication effectively helps in managing blood sugar levels and encourages substantial weight loss